NICOLE BANASIK: Open Payments
NPI 1609521202 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$825 in 38 payments from 18 companies in 2025. Trend: 2023 $1,375 · 2024 $857 · 2025 $825
Food & beverage: $825
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $179 |
| Grifols USA, LLC | 4 | $122 |
| GlaxoSmithKline, LLC. | 5 | $100 |
| Regeneron Healthcare Solutions, Inc. | 3 | $66 |
| United Therapeutics Corporation | 2 | $56 |
| Electromed, Inc. | 3 | $43 |
| HARMONY BIOSCIENCES LLC | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $21 |
Products named: Prolastin-C Liquid, NUCALA, DUPIXENT, BREZTRI, Tyvaso, SMARTVEST, WAKIX, TEZSPIRE.
Industry payments across IA — which companies pay providers there.
